U.S.-China Health Summit 2016 Innovation & Entrepreneurship Competition China Final Concludes Successfully

The China Regional Finals of the 2016 U.S.-China Health Summit Innovation and Entrepreneurship Competition were successfully held in Beijing on August 21, 2016. The U.S.-China Health Summit Innovation and Entrepreneurship Forum aims to inspire entrepreneurs and professionals from both countries to identify unmet needs and seek innovative solutions within the global healthcare ecosystem. By hosting innovation and entrepreneurship competitions in China and the United States, the forum solicits cutting-edge case studies in the medical and health sectors, explores pathways for translational application and sustainable development strategies, and facilitates connections with extensive medical technology resources and markets in both nations.

On-site Group Photo

The China-US Health Summit Innovation and Entrepreneurship Competition is a high-level international forum for intellectual exchange—featuring intense collisions of innovative ideas in healthcare, the seamless integration of traditional Chinese medicine with modern technology, forward-looking insights from leaders in big health investment, and strong support from top universities and hospitals. Co-hosted by the “China-US Health Summit Organization,” “Daoyuan Capital,” and “Qianxun Chuanggu,” the event received nearly 200 outstanding innovative project submissions. These projects spanned numerous areas within healthcare and public health, including biopharmaceuticals, traditional medicine, medical devices, and diagnostic technologies. Participants came from across China, ranging from early-stage startups and R&D teams to student organizations at universities and research institutes. In accordance with the competition’s evaluation criteria, the organizing committee and judges reviewed and adjudicated all entries, ultimately selecting 12 startups and teams to participate in this year’s Innovation and Entrepreneurship Competition.

[Organizer Profile]

The China-US Health Summit Organization is an international non-profit institution dedicated to promoting international exchange and cooperation in the health sector and advancing health as a fundamental human right. The China-US Health Summit seeks to actively foster exchange and collaboration among current and future leaders from China, the United States, and other countries in healthcare-related fields through high-level strategic dialogues, leadership development, and applied research, thereby contributing to the advancement of global health.

[Co-Organizer Profiles]

Daoyuan Capital: Daoyuan Capital is an emerging investment firm focused on the healthcare and medical industry, dedicated to helping outstanding healthcare companies grow, driving innovation in life sciences, supporting entrepreneurs who are honest and innovative, providing society with more and better healthcare products and services, and promoting human well-being.

Qianxun Innovation Valley: Qianxun Innovation Valley is dedicated to providing comprehensive services to entrepreneurs in the healthcare and medical industry, helping them maximize the economic benefits derived from innovative technologies. This initiative aims to drive innovation and development within the healthcare sector, fostering a new ecosystem for entrepreneurship and innovation in the industry.

The event venue was packed with attendees.

Judge Profiles

The 2016 Innovation and Entrepreneurship Competition China Regional Finals lasted five hours, during which the 12 competing teams delivered impressive project presentations to the judges and audience. Topics ranged from reforms and advancements in orthopedic medical care and nursing practices in China, to immediate emergency response for cardiac arrest; from the efficient integration of traditional Chinese medicine theory with modern technology, to the monitoring and treatment of targeted diabetes and tumors. The panel of judges included experts in the health sector, investors, frontline physicians, and executives from healthcare companies. The atmosphere was vibrant, with judges showing strong interest in the projects and engaging in lively discussions with the presenters, while also pointing out shortcomings and offering professional recommendations.

Group Photo of China Region Contestants and Judges

Furthermore, Mr. Wu Dong, President of the Johnson & Johnson Asia Pacific Innovation Center, delivered an inspiring speech on health innovation, outlining the center’s operational model and brand philosophy. Johnson & Johnson believes that entities and organizations within the healthcare sector should not view each other as competitors, but rather collaborate, as our only true adversary is disease itself. Johnson & Johnson is committed to supporting all innovative ideas and partnering with entrepreneurs in the medical and health industries to conquer disease.

Mr. Zhang Dafeng, Founder of Daoyuan Capital, provided a comprehensive interpretation of the firm’s investment philosophy. As a healthcare investment fund that thinks from an entrepreneur’s perspective, Daoyuan Capital is committed to leveraging capital to support the growth of outstanding medical enterprises across all dimensions—including R&D, clinical development, manufacturing, and sales—thereby driving innovation in medical technology and delivering products and services with greater medical value to society.

Chen Yong, President of Beijing Chaoyang Hospital, highly praised the emerging projects in healthcare and health featured in this competition, as well as the new generation of young people with dreams. He provided an in-depth analysis of China’s current medical industry, emphasizing that the primary direction for the future should no longer be solely focused on treating diseases, but rather on how to maintain physical and mental well-being in today’s social environment.

Ultimately, four teams (First Response, XtalPi, Changzhou Jinmu Health, and YiSuifang) emerged as winners in this competition. These four teams will join the four winning teams from the U.S. division (Buoy Health, BrainSpec, Valera Health, and Yiviva) to attend the 6th China-U.S. Health Summit, held in Xi’an, China, from September 2 to 4. They will present their projects and engage in in-depth exchanges with Chinese and American investors, entrepreneurs, and academic experts at the Innovation, Entrepreneurship, and Investment & Financing Forum.

Overview of U.S. Participating Projects

Participant Reflections

“The China-US Health Summit Innovation and Entrepreneurship Competition” is the most outstanding competition I have ever participated in, in terms of professional standards, expert caliber, and breadth of perspective. In particular, this competition placed greater emphasis on technological innovation rather than internet business model innovation, making the contest exceptionally fierce and of very high quality. Furthermore, the event provided participants with highly professional one-on-one coaching. Although I have taken part in many competitions and received coaching in the past, this experience helped me break through previous bottlenecks and can be described as a milestone in my development. I am deeply grateful for this competition! I also look forward to the finals, where the participating teams represent the highest level of medical innovation in both China and the United States. It is a great honor to represent China in this competition, and I hope to work alongside American contestants to explore new approaches to combating disease.

——Yang Feng, CEO of Yi Suifang

“This is an entrepreneurship competition brimming with innovative vitality and a deep commitment to improving public health. I have truly felt the power of China’s medical technology innovation! My sincere thanks to the organizers for providing Chinese healthcare innovation enterprises with a platform for showcasing, exchanging ideas, and fostering continuous learning and progress!”

——Qi Wenbin, CEO of Weiwei Doctor

The successful hosting of the 2016 China-US Health Summit Innovation and Entrepreneurship Competition in both the United States and China has added a vibrant highlight to the development of life sciences and technology in both nations. Building on this success, the China-US Health Summit will continue to foster exchanges in health innovation and facilitate the translation of research outcomes between China and the United States.

The 6th China-US Health Summit will be held in Xi'an, the ancient capital of China, from September 2 to 4. For detailed registration information, please visithttp://summit2016.health-summit.org/Or click “Read Full Article” to access.